gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Dec 2016.

Vasohibin 1

vasohibin-1, Vasohibin, VASH1, VASH
Top mentioned proteins: vascular endothelial growth factor, HAD, CD31, CAN, V1a
Papers on vasohibin-1
Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets.
Sasano et al., Sendai, Japan. In Breast Cancer Res Treat, Jan 2016
We immunolocalized CD34 and αSMA for an evaluation of CAFs and CD31, Vasohibin-1, a specific marker of proliferative endothelial cells and nestin, a marker of pericytes for studying the status of proliferation and maturation of intratumoral microvessel.
The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
Wang et al., Beijing, China. In Tumour Biol, Jan 2016
UNASSIGNED: Vasohibin-1 is an intrinsic inhibitor of angiogenesis induced by VEGF-A.
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.
Fujiwara et al., Tochigi, Japan. In Int J Oncol, Dec 2015
Vasohibin-1 (VASH1) is expressed in vascular endothelial cells stimulated by several angiogenic growth factors and displays autocrine activity to regulate angiogenesis via a negative feedback mechanism.
Hepatic fibrosis and angiogenesis after bile duct ligation are endogenously expressed vasohibin-1 independent.
Kojima et al., Wako, Japan. In Biochem Biophys Res Commun, Aug 2015
Overexpression of exogenous vasohibin-1, a feedback inhibitor of angiogenesis, has been reported to reduce liver fibrosis after bile duct ligation (BDL).
Vasohibin-1 suppresses colon cancer.
Peng et al., Jinan, China. In Oncotarget, May 2015
Vasohibin-1 (VASH1) is an endogenous angiogenesis inhibitor.However, the clinical relevance of VASH1 in colon cancer and its regulations on cancer angiogenesis and cancer cell biological characteristics are still unknown.
[Expression of vasohibin-1 in colorectal cancer tissue and its correlation with vascular endothelial growth factor A and microvessei density].
Suo et al., Tianjin, China. In Zhonghua Wei Chang Wai Ke Za Zhi, Mar 2015
OBJECTIVE: To explore the clinical significance of vasohibin-1 expression in colorectal cancer tissues and its correlation with vascular endothelial growth factor A(VEGF-A) and microvessel density (MVD).
Novel Link between Inhibition of Angiogenesis and Tolerance to Vascular Stress.
Sato, In J Atheroscler Thromb, 2014
One candidate factor of such a system is vasohibin-1 (VASH1), a protein that is preferentially expressed in vascular endothelial cells (ECs).
Angiogenesis Markers in Gynecological Tumors and Patents for Anti-Angiogenic Approach: Review.
Michelin et al., Uberaba, Brazil. In Recent Pat Anticancer Drug Discov, 2014
Studies show that in the most advanced cases of gynecological cancers, biomarkers such as VEGF (Vascular Endothelial Growth Factor), MMP (Matrix Metalloproteinase), CD105 (Endoglin), TIMP (tissue inhibitors of metalloproteinases) and VASH (Vasohibin) are more expressed compared to healthy individuals.
Inhibition of IGF-1-Mediated Cellular Migration and Invasion by Migracin A in Ovarian Clear Cell Carcinoma Cells.
Umezawa et al., Japan. In Plos One, 2014
In the course of our mechanistic study, migracin A was shown to enhance vasohibin-1 expression in an angiogenesis array.
Expression of Vasohibin-1 in Human Carotid Atherosclerotic Plaque.
Miyamoto et al., Kyoto, Japan. In J Atheroscler Thromb, 2014
The expression of Vasohibin-1 (VASH1), a negative feedback regulator of angiogenesis, occurs in the microvessel endothelial cells of various solid tumors and the arterial wall.
The Aplidin analogs PM01215 and PM02781 inhibit angiogenesis in vitro and in vivo.
Untergasser et al., Innsbruck, Austria. In Bmc Cancer, 2014
In addition, Aplidin analogs induced oxidative stress and decreased production of the vascular maturation factors Vasohibin-1 and Dickkopf-3.
Impact of angiogenic and innate immune systems on the corpus luteum function during its formation and maintenance in ruminants.
Matsui et al., Obihiro, Japan. In Reprod Biol, 2013
Vasohibin-1 is a novel negative feedback regulator, which inhibits VEGF-based vasculogenesis.
The vasohibin family: a novel family for angiogenesis regulation.
Sato, Sendai, Japan. In J Biochem, 2013
Recently, vasohibin-1 (VASH1) was isolated as a negative feedback regulator of angiogenesis produced by endothelial cells (ECs) and subsequently vasohibin-2 (VASH2) as a homologue of VASH1.
Emerging roles of immune cells in luteal angiogenesis.
Miyamoto et al., Obihiro, Japan. In Reprod Fertil Dev, 2012
However, the negative feedback regulator vasohibin-1 in the CL prevents excessive tumour-like vasculogenesis, suggesting that CL development has well coordinated time-dependent mechanisms.
A potent anti-angiogenic factor, vasohibin-1, ameliorates experimental bronchiolitis obliterans.
Kondo et al., Sendai, Japan. In Transplant Proc, 2012
Transgene expression of VASH1 in the recipient lung significantly attenuated luminal obliteration of the tracheal allograft and significantly reduced aberrant angiogenesis.
Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells.
Soeda et al., Fukuoka, Japan. In Febs Lett, 2012
Data suggest that vasohibin inhibits cell proliferation of umbilical vein endothelial cells through degradation of HIF-1alpha via proline hydroxylase during oxidative stress. Vasohibin may be a negative feedback regulator of angiogenesis.
Protein kinase C{delta} deficiency accelerates neointimal lesions of mouse injured artery involving delayed reendothelialization and vasohibin-1 accumulation.
Xu et al., Beijing, China. In Arterioscler Thromb Vasc Biol, 2010
PKCdelta deficiency enhances neointimal formation, which is associated with delayed reendothelialization and involves increased cellular vasohibin-1 accumulation.
Isolation of a small vasohibin-binding protein (SVBP) and its role in vasohibin secretion.
Sato et al., Sendai, Japan. In J Cell Sci, 2010
SVBP(CCDC23)acts as a secretory chaperone for VASH1.
[Vasohibin and VEGF protein levels in placentae from pregnancies complicated by severe pre-eclampsia].
Liu et al., Chengdu, China. In Sichuan Da Xue Xue Bao Yi Xue Ban, 2010
Reduced vasohibin and VEGF expression may be responsible, at least in part, for the impaired vascular development which occurs during pre-eclampsia.
Regulation of tumor angiogenesis by EZH2.
Sood et al., Houston, United States. In Cancer Cell, 2010
The increase in endothelial EZH2 is a direct result of VEGF stimulation by a paracrine circuit that promotes angiogenesis by methylating and silencing vasohibin1 (vash1).
share on facebooktweetadd +1mail to friends